Veli Berk

Summary

Publications

  1. ncbi request reprint Efficiency and side effects of sorafenib therapy for advanced hepatocellular carcinoma: a retrospective study by the anatolian society of medical oncology
    Veli Berk
    Department of Medical Oncology, Erciyes University Faculty of Medicine, Turkey E mail
    Asian Pac J Cancer Prev 14:7367-9. 2013
  2. doi request reprint Moxifloxacin-associated neutropenia
    Veli Berk
    Deparment of Medical Oncology, Erciyes University Medical School, Kayseri, Turkey
    Scand J Infect Dis 45:415-6. 2013
  3. ncbi request reprint XELOX vs. FOLFOX4 as second line chemotherapy in advanced pancreatic cancer
    Veli Berk
    Dept of Medical Oncology, Erciyes University Medical Faculty, M Kemal Dedeman Oncology Hospital, Kayseri, Turkey
    Hepatogastroenterology 59:2635-9. 2012
  4. doi request reprint Refractory generalized seizures as a possible side effect of bevacizumab in a colon cancer patient
    Veli Berk
    Department of Medical Oncology, Erciyes University Medical School, 38039 Kayseri, Turkey
    Med Oncol 29:1017-9. 2012
  5. ncbi request reprint Secondline chemotherapy versus best supportive care in patient with malignant pleural mesothelioma: a retrospective study
    Hasan Mutlu
    Department of Medical Oncology, ACIBADEM Kayseri Hospital, Kayseri, Turkey
    Asian Pac J Cancer Prev 14:3887-9. 2013
  6. doi request reprint The efficacy and toxicity of irinotecan with leucovorin and bolus and continuous infusional 5-fluorouracil (FOLFIRI) as salvage therapy for patients with advanced gastric cancer previously treated with platinum and taxane-based chemotherapy regimens
    Ali Osman Kaya
    Bakırkoy Dr Sadl Konuk Training and Research Hospital, Department of Medical Oncology, Istanbul, Turkey
    J Chemother 24:217-20. 2012
  7. ncbi request reprint Gemcitabine plus paclitaxel as second-line chemotherapy in patients with advanced non-small cell lung cancer
    Meltem Baykara
    Department of Medical Oncology, Sakarya University Training and Research Hospital, Sakarya, Turkey
    Asian Pac J Cancer Prev 13:5119-24. 2012
  8. doi request reprint Results of adjuvant FOLFOX regimens in stage III colorectal cancer patients: retrospective analysis of 667 patients
    Dogan Uncu
    Department of Medical Oncology, Ankara Numune Education and Research Hospital, Ankara, Turkey
    Oncology 84:240-5. 2013
  9. ncbi request reprint Long term survivors with metastatic pancreatic cancer treated with gemcitabine alone or plus cisplatin: a retrospective analysis of an Anatolian Society of Medical Oncology multicenter study
    Ali Inal
    Department of Medical Oncology, Dicle University, Diyarbakir, Turkey
    Asian Pac J Cancer Prev 13:1841-4. 2012
  10. doi request reprint Lapatinib plus capecitabine for brain metastases in patients with human epidermal growth factor receptor 2-positive advanced breast cancer: a review of the Anatolian Society of Medical Oncology (ASMO) experience
    Bulent Cetin
    Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey
    Onkologie 35:740-5. 2012

Collaborators

Detail Information

Publications28

  1. ncbi request reprint Efficiency and side effects of sorafenib therapy for advanced hepatocellular carcinoma: a retrospective study by the anatolian society of medical oncology
    Veli Berk
    Department of Medical Oncology, Erciyes University Faculty of Medicine, Turkey E mail
    Asian Pac J Cancer Prev 14:7367-9. 2013
    ..Randomized studies have shown a significant contribution of sorafenib to life expectancy and quality of life of cancer patients. The aim of the present study is to evaluate the efficacy and side effects of sorafenib therapy in Turkey...
  2. doi request reprint Moxifloxacin-associated neutropenia
    Veli Berk
    Deparment of Medical Oncology, Erciyes University Medical School, Kayseri, Turkey
    Scand J Infect Dis 45:415-6. 2013
    ..After discontinuing the moxifloxacin, neutrophil counts were normal on day 4. Clinicians should be aware of the possibility of this adverse effect in patients treated with moxifloxacin...
  3. ncbi request reprint XELOX vs. FOLFOX4 as second line chemotherapy in advanced pancreatic cancer
    Veli Berk
    Dept of Medical Oncology, Erciyes University Medical Faculty, M Kemal Dedeman Oncology Hospital, Kayseri, Turkey
    Hepatogastroenterology 59:2635-9. 2012
    ..Disease control rates were 59%in the XELOX arm and 43% in the FOLFOX4 arm. The median time to progression was 16 weeks in both arms.The median overall survival was 21 weeks with XELOX and 25 weeks with FOLFOX4...
  4. doi request reprint Refractory generalized seizures as a possible side effect of bevacizumab in a colon cancer patient
    Veli Berk
    Department of Medical Oncology, Erciyes University Medical School, 38039 Kayseri, Turkey
    Med Oncol 29:1017-9. 2012
    ..We describe a patient who presented with refractory generalized tonic-clonic seizures after receiving last dose of bevacizumab for treatment of metastatic colorectal cancer with FOLFIRI and bevacizumab regimen...
  5. ncbi request reprint Secondline chemotherapy versus best supportive care in patient with malignant pleural mesothelioma: a retrospective study
    Hasan Mutlu
    Department of Medical Oncology, ACIBADEM Kayseri Hospital, Kayseri, Turkey
    Asian Pac J Cancer Prev 14:3887-9. 2013
    ..Secondline chemotherapy in MPM is still controversial and in this study we evaluated whether it is superior to best supportive care...
  6. doi request reprint The efficacy and toxicity of irinotecan with leucovorin and bolus and continuous infusional 5-fluorouracil (FOLFIRI) as salvage therapy for patients with advanced gastric cancer previously treated with platinum and taxane-based chemotherapy regimens
    Ali Osman Kaya
    Bakırkoy Dr Sadl Konuk Training and Research Hospital, Department of Medical Oncology, Istanbul, Turkey
    J Chemother 24:217-20. 2012
    ..2). The most common observed grade 3/4 toxicities were neutropenia (23.7%), diarrhea (6.2%), and stomatitis (5.2%). FOLFIRI regimen is safe and effective in the second-line treatment of AGC patients pre-treated with cisplatin and taxanes...
  7. ncbi request reprint Gemcitabine plus paclitaxel as second-line chemotherapy in patients with advanced non-small cell lung cancer
    Meltem Baykara
    Department of Medical Oncology, Sakarya University Training and Research Hospital, Sakarya, Turkey
    Asian Pac J Cancer Prev 13:5119-24. 2012
    ....
  8. doi request reprint Results of adjuvant FOLFOX regimens in stage III colorectal cancer patients: retrospective analysis of 667 patients
    Dogan Uncu
    Department of Medical Oncology, Ankara Numune Education and Research Hospital, Ankara, Turkey
    Oncology 84:240-5. 2013
    ..The aim of this study was to assess the use of 5-fluorouracil (5-FU), leucovorin and oxaliplatin (FOLFOX) regimens in clinical practice according to their efficacy and toxicity...
  9. ncbi request reprint Long term survivors with metastatic pancreatic cancer treated with gemcitabine alone or plus cisplatin: a retrospective analysis of an Anatolian Society of Medical Oncology multicenter study
    Ali Inal
    Department of Medical Oncology, Dicle University, Diyarbakir, Turkey
    Asian Pac J Cancer Prev 13:1841-4. 2012
    ....
  10. doi request reprint Lapatinib plus capecitabine for brain metastases in patients with human epidermal growth factor receptor 2-positive advanced breast cancer: a review of the Anatolian Society of Medical Oncology (ASMO) experience
    Bulent Cetin
    Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey
    Onkologie 35:740-5. 2012
    ..We investigated the clinical outcome of patients with brain metastases (BMs) from human epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer (MBC) treated with lapatinib and capecitabine (LC)...
  11. doi request reprint Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected liver metastases from colorectal cancer
    Nedim Turan
    Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey
    Oncology 84:14-21. 2013
    ....
  12. doi request reprint Prognostic value of tumor growth factor levels during chemotherapy in patients with metastatic colorectal cancer
    Mevlude Inanc
    Oncology Department, Mehmet Kemal Dedeman Onkoloji Hastanesi, Erciyes University, 38039, Kayseri, Turkey
    Med Oncol 29:3119-24. 2012
    ..However, meaningful increment was seen HGF levels in PD group. Angiogenic factors and E-selectin provided unique prognostic information in advanced colorectal carcinoma patients...
  13. ncbi request reprint Positive effects of oral β-glucan on mucositis and leukopenia in colorectal cancer patients receiving adjuvant FOLFOX-4 combination chemotherapy
    Halit Karaca
    Department of Medical Oncology, Erciyes University Medical Faculty, Kayseri, Turkey E mail
    Asian Pac J Cancer Prev 15:3641-4. 2014
    ..Oral mucositis and diarrhea were less common in the β-glucan group. We conclude that β-glucan can be used to reduce the adverse effects of chemotherapy. ..
  14. ncbi request reprint Efficacy and toxicity of gemcitabine plus docetaxel combination as a second line therapy for patients with advanced stage soft tissue sarcoma
    Ali Osman Kaya
    Department of Medical Oncology, Bakirkoy Dr Sadi Konuk Training and Research Hospital, Istanbul, Turkey
    Asian Pac J Cancer Prev 13:463-7. 2012
    ..To assess the safety and efficacy of a gemcitabine plus docetaxel regimen as a second line therapy for patients with advanced soft tissue sarcoma (STS) resistant to doxorubicin and ifosfamide-based therapy...
  15. ncbi request reprint Lack of prognostic value of mean corpuscular volume with capecitabine therapy in metastatic breast cancer
    Oktay Bozkurt
    Department of Medical Oncology, Erciyes University Faculty of Medicine, Kayseri, Turkey E mail
    Asian Pac J Cancer Prev 15:2501-4. 2014
    ..The present study investigated the clinical impact of MCV elevation in metastatic breast cancer patients treated with capecitabine...
  16. ncbi request reprint Clinicopathological features in bilateral breast cancer
    Meltem Baykara
    Department of Medical Oncology, Gazi University Medical Faculty, Ankara, Turkey
    Asian Pac J Cancer Prev 13:4571-5. 2012
    ....
  17. ncbi request reprint Haematologic parameters in metastatic colorectal cancer patients treated with capecitabine combination therapy
    Mevlude Inanc
    Kayseri Training and Research Hospital, Kayseri, Turkey E mail
    Asian Pac J Cancer Prev 15:253-6. 2014
    ..PCT and PLT values were higher in patients who received Bevacizumab than those who did not. MCV, PLT, and NLR can be considered as important factors in predicting response to colorectal carcinoma treatment. ..
  18. doi request reprint Paclitaxel plus doxorubicin chemotherapy as second-line therapy in patients with advanced urothelial carcinoma pretreated with platinum plus gemcitabine chemotherapy
    Ali O Kaya
    Department of Medical Oncology, Bakirkoy Dr Sadi Konuk Training and Research Hospital, Istanbul, Turkey
    Onkologie 35:576-80. 2012
    ..We retrospectively evaluated the efficacy and toxicity of paclitaxel plus doxorubicin as a second-line treatment in patients with urothelial carcinoma, who had not responded to a prior platinum plus gemcitabine combination...
  19. ncbi request reprint Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer: multicenter experiences
    Bala Basak Oven Ustaalioglu
    Department of Medical Oncology, Haydarpasa Numune Education and Research Hospital, Istanbul, Turkey E mail
    Asian Pac J Cancer Prev 14:6287-92. 2013
    ..Herein, we evaluated prognostic factors for survival and factors related with adjuvant treatment decisions for stage I and IIA NSCLC patients without lymph node metastasis...
  20. doi request reprint Nuclear factor-kappa B ligand and osteoprotegerin levels in serum and gingival crevicular fluid in patients with bone metastases treated with zoledronic acid
    Mevlude Inanc
    Medical Oncology Department, Kayseri Training and Research Hospital, Kayseri, 38039, Turkey
    Med Oncol 31:837. 2014
    ..OPG levels were greater in patients with 5 or more bone metastases. In patients diagnosed with multiple myeloma, GCF OPG levels were negatively associated with WBC and platelet counts...
  21. doi request reprint Cytokeratin 5/6, c-Met expressions, and PTEN loss prognostic indicators in triple-negative breast cancer
    Mevlude Inanc
    Medical Oncology Department, Erciyes University, Kayseri, 38039, Turkey
    Med Oncol 31:801. 2014
    ....
  22. ncbi request reprint Association of human epidermal growth factor receptor-2 expression and clinicopathological findings in patients with colorectal cancer
    Halit Karaca
    Deparment of Medical Oncology, Erciyes University Medical Faculty, Kayseri, Turkey
    Asian Pac J Cancer Prev 13:6221-5. 2012
    ....
  23. doi request reprint Protective effects of nebivolol against anthracycline-induced cardiomyopathy: a randomized control study
    Mehmet G Kaya
    Department of Cardiology, Erciyes University School of Medicine, Kayseri, Turkey
    Int J Cardiol 167:2306-10. 2013
    ..We aimed to evaluate the effect of prophylactic nebivolol use on prevention of antracycline-induced cardiotoxicity in breast cancer patients...
  24. doi request reprint Assessment of tumor characteristics and factors affecting survival in patients with primary metastatic breast carcinoma: a Multicenter Study of the Anatolian Society of Medical Oncology
    Ummügül Uyetürk
    Department of Medical Oncology, Faculty of Medicine, Abant Izzet Baysal University, 14280, Bolu, Turkey
    Med Oncol 31:929. 2014
    ..Interestingly, patients who underwent primary breast tumor surgery, even those at the metastatic stage upon admission, had the longest survival...
  25. ncbi request reprint Prognostic value of excision repair cross-complementing gene 1 expression for cisplatin-based chemotherapy in advanced gastric cancer
    Metin Ozkan
    Department of Medical Oncology, Medical Faculty, Erciyes University, Kayseri, Turkey
    Asian Pac J Cancer Prev 11:181-5. 2010
    ..Association of excision repair cross-complementing gene 1 (ERCC1) expression and treatment response and survival was evaluated in advanced stages of gastric cancer patients who were given different platinum-based chemotherapy...
  26. doi request reprint Risk factors influencing mortality related to Stenotrophomonas maltophilia infection in hematology-oncology patients
    Hayati Demiraslan
    Department of Infectious Diseases and Clinical Microbiology, Erciyes University Faculty of Medicine, Kayseri, Turkey
    Int J Hematol 97:414-20. 2013
    ....
  27. ncbi request reprint Treatment regimen with bevacizumab decreases mean platelet volume in patients with metastatic colon cancer
    Hasan Mutlu
    Medical Oncology Department, Kayseri Education and Research Hospital, Kayseri, Turkey
    Clin Appl Thromb Hemost 18:546-8. 2012
    ..009, P = .001, and P = .000, respectively). Unlike cases with thrombosis, there is a significant decrease in MPV in combination treatments with bevacizumab...
  28. doi request reprint The effect of bevacizumab on serum soluble FAS/FASL and TRAIL and its receptors (DR4 and DR5) in metastatic colorectal cancer
    Ramazan Yildiz
    Department of Medical Oncology, Gazi University Faculty of Medicine, Besevler, Ankara 06500, Turkey
    J Cancer Res Clin Oncol 136:1471-6. 2010
    ....